Clinical trial
Angiotensin 1-7 as a Therapy for Pneumonia Caused by Coronavirus 2(SARS-CoV-2)
NCT04605887 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiotensin 1-7 as a Therapy for Pneumonia Caused by Coronavirus 2(SARS-CoV-2)
- Lead sponsor
- Rambam Health Care Campus
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 18, 2021
- Completion date
- April 30, 2024
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.